Jade Biosciences, Inc. (JBIO : NASDAQ)
Common Stock
$16.94
USD
-0.20 (-1.17%)
Last updated: 2026-09-18
Get JBIO alerts:
JBIO
Jade Biosciences, Inc.
WealthAwesomePerformance
1 Day
-1.17%
1 Week
-5.31%
1 Month
-24.88%
YTD
+0.41%
Key Statistics
Market Cap
$1.08B
52W High
$28.00
52W Low
$7.30
P/E Ratio
-
50 Day MA
$20.63
200 Day MA
$18.27
Beta
-
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/18/2026 | $17.15 | $17.35 | $16.79 | $16.94 | $16.94 | 2,942,200 |
| 9/17/2026 | $17.03 | $17.74 | $16.94 | $17.14 | $17.14 | 815,700 |
| 9/16/2026 | $17.52 | $17.61 | $16.16 | $16.65 | $16.65 | 1,730,500 |
| 9/15/2026 | $18.16 | $18.16 | $17.02 | $17.38 | $17.38 | 849,800 |
| 9/14/2026 | $18.06 | $18.83 | $17.88 | $18.18 | $18.18 | 829,500 |
| 9/11/2026 | $19.38 | $20.10 | $17.53 | $17.89 | $17.89 | 1,249,200 |
| 9/10/2026 | $18.82 | $19.33 | $18.59 | $19.14 | $19.14 | 1,224,900 |
| 9/9/2026 | $19.43 | $19.98 | $18.79 | $19.06 | $19.06 | 1,507,500 |
| 9/8/2026 | $19.67 | $20.15 | $19.00 | $19.45 | $19.45 | 825,600 |
| 9/4/2026 | $19.86 | $20.35 | $19.70 | $19.90 | $19.90 | 605,000 |
Analyst Price Targets
Based on 3 analysts covering JBIO · as of Sep 17, 2026
Wall Street analysts forecast JBIO stock price to rise 195.9% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$50.13
+195.9% Upside
Current Price
US$16.94
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on JBIO's historical volatility
30-Day Vol
50.5%
Annualized
90-Day Vol
64.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$14.17
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$15.96 | US$13.41 – US$19.00 |
| 60 trading days | US$15.04 | US$11.75 – US$19.24 |
| 90 trading days | US$14.17 | US$10.48 – US$19.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-164.70M
- Profit Margin
- 0.00%
- ROE (TTM)
- -89.19%
- EPS (Diluted)
- -1.07
- Book Value
- 6.92
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About JBIO.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| IMCC | Im Cannabis Corp | $4.23 | +143.10% |
| QNME | Quanome Technologies, Inc. | $0.56 | +92.15% |
| REFR | Research Frontiers Incorporated | $0.65 | +68.13% |
| GIPR | Generation Income Properties Inc | $0.72 | +63.37% |
| MRNO | Murano Global Investments PLC Ordinary Shares | $0.34 | +56.89% |
| TJGC | TJGC Group Limited | $16.84 | +52.95% |
| NBRGR | Newbridge Acquisition Limited Rights | $0.36 | +51.44% |
| ZTG | Zenta Group Company Limited | $1.81 | +50.83% |